GB0706187D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB0706187D0 GB0706187D0 GBGB0706187.2A GB0706187A GB0706187D0 GB 0706187 D0 GB0706187 D0 GB 0706187D0 GB 0706187 A GB0706187 A GB 0706187A GB 0706187 D0 GB0706187 D0 GB 0706187D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0706187.2A GB0706187D0 (en) | 2007-03-29 | 2007-03-29 | Compounds |
| PCT/EP2008/053596 WO2008119717A1 (fr) | 2007-03-29 | 2008-03-27 | Composés présentant une activité au niveau du récepteur m1 et leurs utilisations en médecine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0706187.2A GB0706187D0 (en) | 2007-03-29 | 2007-03-29 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0706187D0 true GB0706187D0 (en) | 2007-05-09 |
Family
ID=38050503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0706187.2A Ceased GB0706187D0 (en) | 2007-03-29 | 2007-03-29 | Compounds |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0706187D0 (fr) |
| WO (1) | WO2008119717A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8288412B2 (en) | 2005-09-30 | 2012-10-16 | Glaxo Group Limited | Compounds which have activity at M1 receptor and their uses in medicine |
| EA016286B1 (ru) | 2005-09-30 | 2012-03-30 | Глэксо Груп Лимитед | Соединения, которые обладают активностью по отношению к рецепторам м, и их применения в медицине |
| JP5209479B2 (ja) | 2005-09-30 | 2013-06-12 | グラクソ グループ リミテッド | Ｍ１受容体にて活性を有するベンゾイミダゾロン類 |
| GB0718415D0 (en) | 2007-09-20 | 2007-10-31 | Glaxo Group Ltd | Compounds |
| CN115745765A (zh) * | 2022-11-22 | 2023-03-07 | 浙大宁波理工学院 | 一种对溴烷基环己酮类化合物的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU701127B2 (en) * | 1994-10-27 | 1999-01-21 | Merck & Co., Inc. | Muscarine antagonists |
| WO1997016186A1 (fr) * | 1995-10-31 | 1997-05-09 | Merck & Co., Inc. | Agonistes de la muscarine |
| WO2001027104A1 (fr) * | 1999-10-13 | 2001-04-19 | Banyu Pharmaceutical Co., Ltd. | Derives d'imidazolidinone a substitution |
| WO2003105781A2 (fr) * | 2002-06-17 | 2003-12-24 | Merck & Co., Inc. | Compositions ophtalmiques destinees a traiter l'hypertension oculaire |
| GB0605786D0 (en) * | 2006-03-22 | 2006-05-03 | Glaxo Group Ltd | Compounds |
| GB0605785D0 (en) * | 2006-03-22 | 2006-05-03 | Glaxo Group Ltd | Compounds |
| GB0605784D0 (en) * | 2006-03-22 | 2006-05-03 | Glaxo Group Ltd | Compounds |
-
2007
- 2007-03-29 GB GBGB0706187.2A patent/GB0706187D0/en not_active Ceased
-
2008
- 2008-03-27 WO PCT/EP2008/053596 patent/WO2008119717A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008119717A1 (fr) | 2008-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0706793D0 (en) | Compounds | |
| GB0704407D0 (en) | Compounds | |
| GB0704394D0 (en) | Compounds | |
| GB0705672D0 (en) | Compounds | |
| GB0706173D0 (en) | Compounds | |
| GB0707092D0 (en) | Compounds | |
| GB0706188D0 (en) | Compounds | |
| GB0706168D0 (en) | Compounds | |
| GB0706165D0 (en) | Compounds | |
| GB0707034D0 (en) | Compounds | |
| GB0706167D0 (en) | Compounds | |
| GB0706187D0 (en) | Compounds | |
| GB0706189D0 (en) | Compounds | |
| GB0706174D0 (en) | Compounds | |
| GB0706170D0 (en) | Compounds | |
| GB0706190D0 (en) | Compounds | |
| GB0706164D0 (en) | Compounds | |
| GB0704939D0 (en) | Compounds | |
| GB0703756D0 (en) | Compounds | |
| GB0701985D0 (en) | Compounds | |
| GB0701977D0 (en) | Compounds | |
| GB0706023D0 (en) | Compounds | |
| GB0706790D0 (en) | Compounds | |
| GB0706929D0 (en) | Compounds | |
| GB0707489D0 (en) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |